1.1. Analysis.
Comparison 1: Nabiximols (tetrahydrocannabinol (THC) and cannabidiol (CBD)) versus placebo for individuals with opioid‐refractory cancer pain, Outcome 1: Patient Global Impression of Change (PGIC) of much improved or very much improved